دورية أكاديمية
A novel, immunotherapy-based approach for the treatment of relapsed/refractory multiple myeloma (RRMM): Updated phase 1b results for daratumumab in combination with teclistamab (a BCMA x CD3 bispecific antibody).
| العنوان: | A novel, immunotherapy-based approach for the treatment of relapsed/refractory multiple myeloma (RRMM): Updated phase 1b results for daratumumab in combination with teclistamab (a BCMA x CD3 bispecific antibody). |
|---|---|
| المؤلفون: | Rodríguez-Otero, Paula, D'Souza, Anita Christine, Prior, Thomas, Vandenberk, Lien, Vishwamitra, Deeksha, Krishnan, Amrita Y., Wang Lin, Shun Xin, Oriol Rocafiguera, Albert, van de Donk, Niels W.C.J., Smit, Marie-Anne Damiette, Morillo, Daniel, Reece, Donna Ellen, Martin, Thomas G., Hurd, David Duane, Dholaria, Bhagirathbhai R., Sureda Balari, Anna, Chari, Ajai, Mateos, Maria-Victoria, Rosiñol, Laura, Wäsch, Ralph |
| المصدر: | ISSN: 1527-7755. |
| سنة النشر: | 2022 |
| المجموعة: | University of Freiburg: FreiDok |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | https://freidok.uni-freiburg.de/data/244775Test |
| DOI: | 10.1200/jco.2022.40.16_suppl.8032 |
| الإتاحة: | https://doi.org/10.1200/jco.2022.40.16_suppl.8032Test https://freidok.uni-freiburg.de/data/244775Test |
| رقم الانضمام: | edsbas.AF5913BD |
| قاعدة البيانات: | BASE |
| DOI: | 10.1200/jco.2022.40.16_suppl.8032 |
|---|